Infectious diseases researcher recognised
UNSW infectious diseases researcher Dr Lise Lafferty has been recognised with the Paul Bourke Award for her approach to managing hepatitis C in prisons.
Lafferty is a Senior Research Fellow in the Centre for Social Research in Health (CSRH) in UNSW Arts, Design & Architecture and the Surveillance Evaluation and Research Program, The Kirby Institute.
The Academy of the Social Sciences’ Paul Bourke Award for early-career research recognises Lafferty for her “significant contributions to the field of infectious diseases, with a particular focus on hepatitis C in the challenging context of prison settings”.
“I am indebted to the people in prison who openly discuss with me their hepatitis C care engagement, risk practices and concerns of reinfection in the absence of primary prevention strategies, such as prison needle syringe programs. It is a privilege to be entrusted with such crucial information regarding the health of people who are incarcerated,” Lafferty said.
Lafferty said she was grateful to Professors Carla Treloar and Andrew Lloyd at UNSW for their mentorship throughout her academic career, particularly in conducting prison-based research. She also thanked Professors Alison Ritter and Carla Treloar, Fellows of the Academy, for nominating her for the award.
Academy President Professor Richard Holden extended his congratulations to the recipients, as well as the nominees, acknowledging their dedication to advancing knowledge through their social science research.
Professor Kylie Valentine, CSRH Director, said, “Lise is an exceptional early-career researcher and an extremely worthy recipient of this prestigious award. She is an innovative and dedicated researcher who can communicate her findings to broad and diverse audiences. We are proud to have this emerging leader as our colleague.”
Since completing her PhD, Dr Lafferty has established herself as a global leading expert on hepatitis C in the prison setting. Her work unpacks the social and behavioural risks of hepatitis C transmission in the prison environment as well as identifying ways to enhance care engagement among this population group.
Lafferty has been a chief investigator on significant grants, including the Medical Research Future Fund (MRFF), National Health and Medical Research Council (NHMRC), Commonwealth Department of Health and Canadian Institute of Health Research, totalling more than $15 million.
In 2022, Lafferty received the Dean’s Award for Outstanding Achievement by an Early Career Academic, UNSW Arts, Design & Architecture, due to her ‘rising star’ status. She has been recognised for her contributions to prison health through an Honourable Mention of the Levinia Crooks Emerging Leader Award in Viral Hepatitis (Justice and Correctional Health Sector), Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine.
Lafferty is the first social scientist to receive recognition in the Viral Hepatitis award since its commencement in 2018. She was awarded Best Research Article (2020) and Highly Commended (2021), in the Early Career Publication Award, UNSW Arts, Design & Architecture.
New public health campaign to improve pregnancy outcomes
The Preterm Birth Prevention campaign 'See, Stop, Scan' aims to promote engagement...
Feedback sought on genomic-led cancer control
The framework is designed to guide health professionals, researchers, health services and policy...
Can you die from long COVID? The answer is not so simple
Nearly five years into the pandemic, COVID is feeling less central to our daily lives.